Novartis says Japanese study shows benefits of Diovan - MarketWatch
| Novartis says Japanese study shows benefits of Diovan MarketWatch - In addition to its impact on overall cardiovascular events and stroke, Diovan demonstrated relative reductions of 65% in angina pectoris - recurring acute … First Controlled Large-Scale Intervention Angiotensin Receptor … Valsartan plus optimal medical therapy provides additional … APS: First Controlled Large-Scale Intervention Angiotensin ……. |
More: continued here